We are live on
!
Find out more
SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
175 hedge funds and large institutions have $374M invested in Sage Therapeutics in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 66 increasing their positions, 51 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
155% more call options, than puts
Call options by funds: $3.95M | Put options by funds: $1.55M
29% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 51
4.69% less ownership
Funds ownership: 88.92% → 84.24% (-4.7%)
9% less funds holding
Funds holding: 193 → 175 (-18)
36% less capital invested
Capital invested by funds: $581M → $374M (-$207M)
55% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 33
Holders
175
Holders Change
-18
Holders Change %
-9.33%
% of All Funds
2.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
66
Reduced
51
Closed
33
Calls
$3.95M
Puts
$1.55M
Net Calls
+$2.4M
Net Calls Change
-$5.52M
Top Buyers
| 1 |
Millennium Management
New York
|
+$11.6M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$8.66M |
| 3 |
State Street
Boston,
Massachusetts
|
+$4.13M |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$3.02M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.95M |
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$9.61M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6M |
| 3 |
Morgan Stanley
New York
|
-$5.33M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$5.31M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$5.25M |
